ZYDELIG (idelalisib) Gilead sciences inc Patent: 6,800,620 Expiration: Apr 24, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug P…
Drug Patent Expirations for the Week of April 18, 2021 Read Post »
ZYDELIG (idelalisib) Gilead sciences inc Patent: 6,800,620 Expiration: Apr 24, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug P…
Drug Patent Expirations for the Week of April 18, 2021 Read Post »
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first …
Annual Drug Patent Expirations for ALTABAX Altabax is a drug marketed by Almirall and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Almirall drug ALTABAX appeared first…
Annual Drug Patent Expirations for ERAXIS Eraxis is a drug marketed by Vicuron and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Vicuron drug ERAXIS appeared first on D…
Annual Drug Patent Expirations for REQUIP+XL Requip Xl is a drug marketed by Glaxosmithkline Llc and is included in one NDA. There are two patents protecting this drug and seven…
The post New patent expiration for Glaxosmithkline Llc drug REQUIP XL app…
New patent expiration for Glaxosmithkline Llc drug REQUIP XL Read Post »
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Abraxis Bioscience and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent expiration for Abraxis Bioscience drug ABRAXANE a…
New patent expiration for Abraxis Bioscience drug ABRAXANE Read Post »
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are sixteen patents protecting this drug. XHANCE drug…
The post New patent expiration for Optinose Us drug XHANCE appeared first on…
New patent expiration for Optinose Us drug XHANCE Read Post »
Annual Drug Patent Expirations for SEEBRI Seebri is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent expiration for Novartis drug SEEBRI appeared first o…
Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…
The post New patent expiration for Novartis drug UTIBRON appeared fi…